
Driving Innovation and Extending Its Global Reach
Last year, Rentschler Biopharma, a German contract development and manufacturing organization (CDMO) for biopharmaceuticals, announced its "Strategy 2025."
Last year, Rentschler Biopharma, a German contract development and manufacturing organization (CDMO) for biopharmaceuticals, announced its "Strategy 2025."
The pharmaceutical industry continues to grow and is estimated to be worth $1.5 trillion by 2021.